Cipla receives U.S. FDA approval for generic of asthma, COPD drug
This is first dry powder inhaler (DPI) approval from Cipla’s U.S.-based manufacturing network. The product is expected to be launched in the second quarter (Q2) of FY27 in the U.S
· 7/28/2026, 3:36:01 PM· 2 min read
This is first dry powder inhaler (DPI) approval from Cipla’s U.S.-based manufacturing network. The product is expected to be launched in the second quarter (Q2) of FY27 in the U.S
Read original story →Related stories
business
Some parents on benefits to get up to £4,500 for child starting apprenticeship
business
City Union Bank Q1 net rises 25% to ₹383 crore
business
VST invests ₹100 crore to open Global Tech Centre in Hosur
business